-
公开(公告)号：US20220265642A1
公开(公告)日：2022-08-25
申请号：US17709324
申请日：2022-03-30
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US20240000776A1
公开(公告)日：2024-01-04
申请号：US18463252
申请日：2023-09-07
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496 , A61K31/02 , A61K31/04 , A61K31/10 , A61K31/18 , A61K31/33 , A61K31/436 , A61K31/437 , A61K31/4375 , A61K31/45 , A61K31/505 , A61K31/63 , A61K39/395
CPC分类号： A61K31/496 , A61K31/02 , A61K31/04 , A61K31/10 , A61K31/18 , A61K31/33 , A61K31/436 , A61K31/437 , A61K31/4375 , A61K31/45 , A61K31/505 , A61K31/63 , A61K39/39558 , A61K2039/545
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US11110087B2
公开(公告)日：2021-09-07
申请号：US17187468
申请日：2021-02-26
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496 , A61P35/02 , A61P35/00 , A61K39/395
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US20210177838A1
公开(公告)日：2021-06-17
申请号：US17187468
申请日：2021-02-26
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US11590128B2
公开(公告)日：2023-02-28
申请号：US17834709
申请日：2022-06-07
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496 , A61K31/02 , A61K31/04 , A61K31/10 , A61K31/18 , A61K31/33 , A61K31/436 , A61K31/437 , A61K31/4375 , A61K31/45 , A61K31/505 , A61K31/63 , A61K39/395 , A61K39/00
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US20220370441A1
公开(公告)日：2022-11-24
申请号：US17834709
申请日：2022-06-07
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496 , A61K31/18 , A61K31/10 , A61K31/04 , A61K31/02 , A61K31/33 , A61K31/437 , A61K31/45 , A61K31/4375 , A61K31/63 , A61K39/395 , A61K31/436 , A61K31/505
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US20220211696A1
公开(公告)日：2022-07-07
申请号：US17395366
申请日：2021-08-05
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US20240108616A1
公开(公告)日：2024-04-04
申请号：US18506606
申请日：2023-11-10
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496 , A61K31/02 , A61K31/04 , A61K31/10 , A61K31/18 , A61K31/33 , A61K31/436 , A61K31/437 , A61K31/4375 , A61K31/45 , A61K31/505 , A61K31/63 , A61K39/395
CPC分类号： A61K31/496 , A61K31/02 , A61K31/04 , A61K31/10 , A61K31/18 , A61K31/33 , A61K31/436 , A61K31/437 , A61K31/4375 , A61K31/45 , A61K31/505 , A61K31/63 , A61K39/39558 , A61K2039/545
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US20230226045A1
公开(公告)日：2023-07-20
申请号：US18157680
申请日：2023-01-20
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496 , A61K31/02 , A61K31/04 , A61K31/10 , A61K31/18 , A61K31/33 , A61K31/436 , A61K31/437 , A61K31/4375 , A61K31/45 , A61K31/505 , A61K31/63 , A61K39/395
CPC分类号： A61K31/496 , A61K31/02 , A61K31/04 , A61K31/10 , A61K31/18 , A61K31/33 , A61K31/436 , A61K31/437 , A61K31/4375 , A61K31/45 , A61K31/505 , A61K31/63 , A61K39/39558 , A61K2039/545
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
公开(公告)号：US10993942B2
公开(公告)日：2021-05-04
申请号：US16827650
申请日：2020-03-23
发明人： Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
IPC分类号： A61K31/496 , A61P35/02 , A61P35/00
摘要： The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.026 秒)
